Rodrigo, M.J. Cardiel, M.J. Fraile, J.M. Mendez-Martinez, S. Martinez-Rincon, T. Subias, M. Polo, V. Ruberte, J. Ramirez, T. Vispe, E. Luna, C. Mayoral, J.A. Garcia-Martin, E. Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model Biomater. sci. eng 2020

http://zaguan.unizar.es/record/107335/files/texto_completo.pdf; http://zaguan.unizar.es/record/107335/files/texto_completo.jpg?subformat=icon;

Imported from Invenio.